Showing results (281-290 of 480) with videos related to
Sort By:
Pageof 48
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 9, 2020
Multicenter, Double-Blind, Randomized Trial of Emricasan in Hepatitis C-Treated Liver Transplant Recipients With Residual Fibrosis or CirrhosisEthan M Weinberg, Michael P Curry, Catherine T Frenette, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 21, 2021
Inpatient Frailty Assessment Is Feasible and Predicts Nonhome Discharge and Mortality in Decompensated CirrhosisMarina Serper, Sunny Y Tao, Dorothea S Kent, et al.Digestive Diseases and Sciences|December 28, 2016
Gender-Specific Differences in Baseline, Peak, and Delta Serum Creatinine: The NACSELD ExperienceJacqueline G O'Leary, Florence Wong, K Rajender Reddy, et al.Research Square|June 5, 2026
Ahead, a Novel Validated Machine Learning Model for Clinical Diagnosis of Alcohol Associated HepatitisDavid Malicote, Gene Im, Ethan Weinberg, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 5, 2023
Validation of a Clinical Risk-based Classification System in a Large Nonalcoholic Fatty Liver Disease Real-world CohortArun J Sanyal, Breda Munoz, Kenneth Cusi, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 18, 2022
Outcomes of patients with acute liver failure listed for liver transplantation: A multicenter prospective cohort analysisConstantine J Karvellas, Thomas M Leventhal, Jorge L Rakela, et al.Journal of Hepatology|July 2, 2005
Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirinPeter Ferenci, Michael W Fried, Mitchell L Shiffman, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 31, 2005
Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver diseaseRolland C Dickson, Norah A Terrault, Michael Ishitani, et al.Hepatology (Baltimore, Md.)|February 28, 2007
Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-gamma1b in chronic hepatitis C patients with advanced fibrosis or cirrhosisPaul J Pockros, Lennox Jeffers, Nezam Afdhal, et al.The Journal of Organic Chemistry|March 26, 2015
An enantioselective formal synthesis of montelukast sodiumSatyanarayana Bollikonda, Saravanan Mohanarangam, Rajender Reddy Jinna, et al.Pageof 48